Pharmaceuticals by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceuticals ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- DKK 34.67T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | DKK 66B | DKK 436.89 | 2.20% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | DKK 55.1B | DKK 795.42 | 0.06% up | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | DKK 33.2B | DKK 589.21 | 0.63% down | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | DKK 55.5B | DKK 849.78 | 0.01% down | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | DKK 58.2B | DKK 2,081.72 | 0.10% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | DKK 48.7B | DKK 349.43 | 0.76% down | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | DKK 31B | DKK 185.96 | 1.19% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | DKK 40.9B | DKK 2,043.30 | 2.02% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | DKK 61.6B | DKK 648.41 | 1.40% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | DKK 53.5B | DKK 318.07 | 2.66% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | DKK 30.4B | DKK 277.97 | 3.00% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | DKK 103.5B | DKK 531.39 | 1.50% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | DKK 31.7B | DKK 90.32 | 4.61% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | DKK 33.9B | DKK 194.99 | 2.71% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | DKK 40.8B | DKK 624.32 | 0.40% down | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | DKK 32.9B | DKK 342.95 | 1.55% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | DKK 44.7B | DKK 658.84 | 0.34% up | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | DKK 34.5B | DKK 412.76 | 0.31% up | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | DKK 65.2B | DKK 2,807.37 | 2.41% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | DKK 106.7B | DKK 1,661.73 | 1.27% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | DKK 51.2B | DKK 468.08 | 2.01% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | DKK 41.9B | DKK 296.19 | 1.07% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | DKK 35.9B | DKK 850.40 | 0.71% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | DKK 79.5B | DKK 410.30 | 2.87% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | DKK 26.6B | DKK 194.21 | 3.03% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | DKK 90B | DKK 180.10 | 2.21% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | DKK 179.5B | DKK 818.09 | 1.52% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | DKK 191.8B | DKK 264.76 | 0.34% up | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | DKK 47.9B | DKK 910.66 | 1.74% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | DKK 21.4B | DKK 110.53 | 0.65% up | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | DKK 51.5B | DKK 656.05 | 1.19% up | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | DKK 59.2B | DKK 73.96 | 1.69% up | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | DKK 49.9B | DKK 570.19 | 1.88% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | DKK 120.9B | DKK 1,843.67 | 0.27% down | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | DKK 166.7B | DKK 3,915.00 | 1.68% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | DKK 232.5B | DKK 572.24 | 0.56% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | DKK 140B | DKK 1,045.19 | 2.03% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | DKK 44.1B | DKK 1,084.96 | 0.91% up | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | DKK 51.3B | DKK 147.38 | 2.37% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | DKK 162B | DKK 141.35 | 1.39% up | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | DKK 85.2B | DKK 102.15 | 1.32% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | DKK 337.4B | DKK 289.17 | 0.47% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | DKK 1.09T | DKK 192.06 | 1.04% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | DKK 834.7B | DKK 408.33 | 2.36% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | DKK 268.6B | DKK 467.22 | 0.20% down | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | DKK 673.9B | DKK 6,514.76 | 0.22% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | DKK 924.5B | DKK 3,646.45 | 0.13% up | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | DKK 216.3B | DKK 350.72 | 0.98% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | DKK 315B | DKK 2,757.88 | 2.10% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | DKK 1.23T | DKK 709.87 | 0.55% down | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | DKK 2.35T | DKK 951.56 | 2.64% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | DKK 3.48T | DKK 1,966.07 | 1.50% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | DKK 39.7B | DKK 58.32 | 0.87% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | DKK 1.19T | DKK 271.00 | 2.32% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | DKK 8.44T | DKK 9,470.87 | 1.85% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | DKK 667.8B | DKK 333.14 | 0.75% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | DKK 4.52T | DKK 1,875.92 | 1.26% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | DKK 774.1B | DKK 322.37 | 0.50% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | DKK 2.01T | DKK 1,065.54 | 1.77% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | DKK 1.89T | DKK 1,220.65 | 1.76% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | DKK 465.5B | DKK 145.71 | 1.22% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8168 DKK).
Questions and answers
Which pharmaceuticals rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceuticals ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceuticals are in this ranking?
61 are ranked by short interest.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by short interest have a combined market value of DKK 34.67T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceuticals by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.